Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

Cell(2022)10.1016/j.cell.2022.09.032Source: DataRank Database

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses is a research paper published in Cell (2022). On theSindex it has a DataRank of 0. It has been cited 68 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access68 citations

Download PDF

Cite:

Linked data & code

gen cellosaurus nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 6.08)OA: bronzeTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Lela Kardava,Omar El Merhebi ORCID,Sandeep Narpala ORCID,Leonid Serebryannyy ORCID,Bob C. Lin ORCID

Live enrichment

PubMed:36257313 PMC:PMC9513331 OpenAlex:https://openalex.org/W4297294440

Intramural NIH HHS

Grant: ZIA AI001325

National Institutes of Health

Vaccine Research Center

National Institute of Allergy and Infectious Diseases

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

FWCI

6.08

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

bronze

journalhttp://www.cell.com/article/S009286742201251X/pdf

publisherhttp://www.cell.com/article/S009286742201251X/pdf

journalhttps://doi.org/10.1016/j.cell.2022.09.032

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36257313

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9513331

Fields of Study

SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesAnimal Virus Infections Studies

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesmRNA VaccinesAntibodies, ViralB-LymphocytesHumansVaccinationViral VaccinesAntibodies, Neutralizing

Keywords

BiologyVaccinationImmunologyAntibodyImmune systemImmunityVirologyBooster (rocketry)InfectionAntibodiesVariantsMemory B CellsBooster VaccinationMrna VaccinesSars-cov-2Hybrid Immunity

Sustainable Development Goals

SDG 0: Good health and well-being